trial · primary record
Alpelisib
PIK3CA-related Overgrowth Spectrum (PROS)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 140 |
| Primary completion | 2031-06-18 |
| Primary endpoint | Proportion of participants with a confirmed objective response by BIRC |
| Registry ID | NCT06997588 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:54.503Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06997588
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.